Craig Hopkinson
Chief Tech/Sci/R&D Officer at ALKERMES PLC
Net worth: 3 M $ as of 31/03/2024
Profile
Craig C. Hopkinson is Chief Medical Officer & EVP-Research & Development at Alkermes Plc. In the past Dr. Hopkinson occupied the position of Senior VP & Head-Global Medical Affairs at Vertex Pharmaceuticals, Inc. and President-Eisai Value Maximization Systems at Eisai, Inc. Dr. Hopkinson received an undergraduate degree from the University of the Free State.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/02/2024 | 109,709 ( 0.07% ) | 3 M $ | 31/03/2024 |
Craig Hopkinson active positions
| Companies | Position | Start |
|---|---|---|
| ALKERMES PLC | Chief Tech/Sci/R&D Officer | 30/05/2017 |
Former positions of Craig Hopkinson
| Companies | Position | End |
|---|---|---|
| ALBIREO PHARMA, INC. | Director/Board Member | 02/03/2023 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 01/05/2017 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | President | 01/12/2012 |
Training of Craig Hopkinson
| University of the Free State | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| ALKERMES PLC | Health Technology |
| Private companies | 3 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Craig Hopkinson
